EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology

Huirong Xu iD, Meiyue Dong, Ruikun Du, Chengcheng Zhang iD, Zinuo Chen, Guangyu Tian, Qinghua Cui iD, Kejian Li iD

Animal Models and Experimental Medicine · 2024

DOI: 10.1002/ame2.12440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2024. Verfasst von Huirong Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Network Pharmacology, SARS-CoV-2, COVID-19 Drug Treatment. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Qingdao Science and Technology Demonstration Program for the Benefit of the People, Shandong Province, China, Key R&D Project in Shandong Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

YangshenDingzhi granules (YSDZ) are clinically effective in preventing and treating COVID‐19. The present study elucidates the underlying mechanism of YSDZ intervention in viral pneumonia by employing serum pharmacochemistry and network pharmacology.

Methods

The chemical constituents of YSDZ in the blood were examined using ultra‐performance liquid chromatography‐quadrupole/orbitrap high‐resolution mass spectrometry (UPLC‐Q‐Exactive Orbitrap MS). Potential protein targets were obtained from the SwissTargetPrediction database, and the target genes associated with viral pneumonia were identified using GeneCards, DisGeNET, and Online Mendelian Inheritance in Man (OMIM) databases. The intersection of blood component‐related targets and disease‐related targets was determined using Venny 2.1. Protein–protein interaction networks were constructed using the STRING database. The Metascape database was employed to perform enrichment analyses of Gene Ontology (GO) functions and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathways for the targets, while the Cytoscape 3.9.1 software was utilized to construct drug‐component‐disease‐target‐pathway networks. Further, in vitro and in vivo experiments were performed to establish the therapeutic effectiveness of YSDZ against viral pneumonia.

Results

Fifteen compounds and 124 targets linked to viral pneumonia were detected in serum. Among these, MAPK1, MAPK3, AKT1, EGFR, and TNF play significant roles. In vitro tests revealed that the medicated serum suppressed the replication of H1N1, RSV, and SARS‐CoV‐2 replicon. Further, in vivo testing analysis shows that YSDZ decreases the viral load in the lungs of mice infected with RSV and H1N1.

Conclusion

The chemical constituents of YSDZ in the blood may elicit therapeutic effects against viral pneumonia by targeting multiple proteins and pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalNetwork PharmacologySARS-CoV-2COVID-19 Drug TreatmentAnimalsMiceProtein Interaction MapsMaleCOVID-19Pneumonia, ViralAntiviral AgentsHumans

Stichwörter der Autor:innen

YangshenDingzhi granulesnetwork pharmacologypharmacodynamical material basisserum pharmacochemistryviral pneumonia

Substanzen

Drugs, Chinese HerbalAntiviral Agents

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, China.
  • College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.

ORCID-Profile: Huirong Xu, Chengcheng Zhang, Qinghua Cui, Kejian Li

Förderung

  • Qingdao Science and Technology Demonstration Program for the Benefit of the People, Shandong Province, China
  • Key R&D Project in Shandong Province, China

Zitieren

APA

Xu, H., Dong, M., Du, R., Zhang, C., Chen, Z., Tian, G., Cui, Q., & Li, K. (2024). Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12440

Vancouver

Xu H, Dong M, Du R, Zhang C, Chen Z, Tian G, et al. Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology. Animal Models and Experimental Medicine. 2024. doi:10.1002/ame2.12440

BibTeX
@article{Xu2024,
  author = {Xu, Huirong and Dong, Meiyue and Du, Ruikun and Zhang, Chengcheng and Chen, Zinuo and Tian, Guangyu and Cui, Qinghua and Li, Kejian},
  title = {Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology},
  journal = {Animal Models and Experimental Medicine},
  year = {2024},
  doi = {10.1002/ame2.12440}
}
Kostenlos starten →